The Food and Drug Administration has earned well-deserved criticism for negligent oversight of the safety of drugs on the U.S. market. Last week, the federal agency launched a new section of its website to try and remedy some of the lapse in information available to the public.
Information on drug safety has been consolidated on the FDA’s website at http://www.fda.gov/cder/drugSafety.htm. Consumers and health professionals can now find information about the FDA’s drug safety efforts on the Web.
The webpage is designed to allow for drugs to be searched by name for the “latest safety information.” Drugs that carry FDA safety alerts are highlighted.
Information on recent agency action regarding drug safety is also provided under public health advisories. Agency actions are listed by date. And extensive data and recommendations that appear on drug labels are also provided.
The site even allows for public reporting of an adverse reaction to a drug to the FDA under the Adverse Event Reporting System (AERS) link. The MedWatch section also provides recent drug safety notices from the MedWatch system.
As noted on the website, the FDA was required to create the new drug safety resource by the Food and Drug Administration Amendments Act of 2007.